SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Jérôme Stirnemann, Najett Kaddouri, Medhi Khellaf, Anne-Sophie Morin, Virginie Prendki, Marc Michel, Arsène Mekinian, Philippe Bierling, Pierre Fenaux, Bertrand Godeau, Olivier Fain, Vincristine efficacy and safety in treating immune thrombocytopenia: a retrospective study of 35 patients, European Journal of Haematology, 2015, 95, 3
  2. 2
    Huyen Tran, Tim Brighton, Andrew Grigg, Simon McRae, Joanna Dixon, Daniel Thurley, Maher K. Gandhi, Matt Truman, Paula Marlton, John Catalano, A multi-centre, single-arm, open-label study evaluating the safety and efficacy of fixed dose rituximab in patients with refractory, relapsed or chronic idiopathic thrombocytopenic purpura (R-ITP1000 study), British Journal of Haematology, 2014, 167, 2
  3. 3
    S. Audia, D. Lakomy, J. Guy, V. Leguy-Seguin, S. Berthier, S. Aho, B. Lorcerie, B. Bonnotte, Traitement du purpura thrombopénique immunologique : étude rétrospective de 40 patients, La Revue de Médecine Interne, 2010, 31, 5, 337

    CrossRef

  4. 4
    F. Rodeghiero, R. Stasi, T. Gernsheimer, M. Michel, D. Provan, D. M. Arnold, J. B. Bussel, D. B. Cines, B. H. Chong, N. Cooper, B. Godeau, K. Lechner, M. G. Mazzucconi, R. McMillan, M. A. Sanz, P. Imbach, V. Blanchette, T. Kuhne, M. Ruggeri, J. N. George, Standardization of terminology, definitions and outcome criteria in immune thrombocytopenic purpura of adults and children: report from an international working group, Blood, 2009, 113, 11, 2386

    CrossRef

  5. 5
    B. Godeau, P. Bierling, Purpura thrombopénique auto-immun, EMC - Hématologie, 2008, 3, 2, 1

    CrossRef

  6. 6
    Thein H. Oo, Rituximab Can Induce a Durable Response in Refractory Immune Thrombocytopenic Purpura Associated with Chronic Lymphocytic Leukemia: Case Report and Review of the Literature, Clinical Leukemia, 2008, 2, 2, 140

    CrossRef

  7. 7
    Donald M. Arnold, John G. Kelton, Current Options for the Treatment of Idiopathic Thrombocytopenic Purpura, Seminars in Hematology, 2007, 44, S12

    CrossRef

  8. 8
    S Gerald Sandler, S Osman Tutuncuoglu, Immune thrombocytopenic purpura – current management practices, Expert Opinion on Pharmacotherapy, 2004, 5, 12, 2515

    CrossRef

  9. 9
    Roberto Stasi, Drew Provan, Management of Immune Thrombocytopenic Purpura in Adults, Mayo Clinic Proceedings, 2004, 79, 4, 504

    CrossRef

  10. 10
    Sophocles Tsoussis, Fotini Ekonomidou, Erene Vourliotaki, Ioannis Karalis, Alkiviades Dermitzakis, Successful treatment of idiopathic thrombocytopenic purpura-like syndrome in a cancer patient with low-dose interferon: Case report and review of the literature, American Journal of Hematology, 2004, 76, 4
  11. 11
    Michael D. Tarantino, George R. Buchanan, The pros and cons of drug therapy for immune thrombocytopenic purpura in children, Hematology/Oncology Clinics of North America, 2004, 18, 6, 1301

    CrossRef

  12. 12
    Emmanuelle Bourgeois, Marie T. Caulier, Catherine Delarozee, Marc Brouillard, Francis Bauters, Pierre Fenaux, Long-term follow-up of chronic autoimmune thrombocytopenic purpura refractory to splenectomy: a prospective analysis, British Journal of Haematology, 2003, 120, 6
  13. 13
    R. McMillan, Classical management of refractory adult immune (idiopathic) thrombocytopenic purpura, Blood Reviews, 2002, 16, 1, 51

    CrossRef

  14. 14
    Douglas B. Cines, Victor S. Blanchette, Immune Thrombocytopenic Purpura, New England Journal of Medicine, 2002, 346, 13, 995

    CrossRef

  15. 15
    A.A.N. Giagounidis, J. Anhuf, P. Schneider, U. Germing, D. Söhngen, K. Quabeck, C. Aul, Treatment of relapsed idiopathic thrombocytopenic purpura with the anti-CD20 monoclonal antibody rituximab: a pilot study, European Journal of Haematology, 2002, 69, 2
  16. 16
    James N George, Kiarash Kojouri, Jedidiah J Perdue, Sara K Vesely, Management of patients with chronic, refractory idiopathic thrombocytopenic purpura, Seminars in Hematology, 2000, 37, 3, 290

    CrossRef

  17. 17
    Michael D Tarantino, Treatment options for chronic immune (idiopathic) thrombocytopenia purpura in children, Seminars in Hematology, 2000, 37, 35

    CrossRef

  18. 18
    Shmuel Gillis, Amiram Eldor, 6 Immune thrombocytopenic purpura in adults: clinical aspects, Baillière's Clinical Haematology, 1998, 11, 2, 361

    CrossRef

  19. 19
    Arne Böcher, Franz -Geert Hagmann, Helmut Kreiter, Die chronische idiopathische thrombozytopenische Purpura, Medizinische Klinik, 1998, 93, 12, 707

    CrossRef

  20. 20
    B Godeau, P Bierling, Traitement du purpura thrombopénique auto-immun de l'adulte, La Revue de Médecine Interne, 1996, 17, 8, 661

    CrossRef

  21. 21
    Marie Thérèse Caulier, Christian Rose, Marie Thérèse Roussel, Claude Huart, Francis Bauters, Pierre Fenaux, Pulsed high-dose dexamethasone in refractory chronic idiopathic thrombocytopenic purpura: a report on 10 cases, British Journal of Haematology, 1995, 91, 2
  22. 22
    Marie Thearegse Caulier, Franck Darloy, Christian Rose, Ghislaine Camier, Pierre Morel, Francis Bauters, Pierre Fenaux, Splenic irradiation for chronic autoimmune thrombocytopenic purpura in patients with contra-indications to splenectomy, British Journal of Haematology, 1995, 91, 1
  23. 23
    Samir Dalia, Benjamin Djulbegovic, Acute and Chronic Immune Thrombocytopenia: Biology, Diagnosis, and Management,